Cal Domingue, PA
Surgical · New Orleans, LANPI 1437134707
Payments from drug & device makers
What this record shows
This record is dominated by other: $1,789 of the $2,617 with a category attached, or 68.4%. Angiodynamics, Inc. accounts for 68.4% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2024 at $1,056 and has fallen 80.9% since, to $201 in 2025.
Across 38 payments — averaging $68.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$2K
- Merck$118
- Bard Peripheral Vascular, Inc.$111
- Kerecis Limited$101
- Johnson & Johnson$55
- Medtronic$53
- plus $390 from 15 others
What the payments were for
- Food & beverage$82732%
- Other$1,78968%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 3 | $1,789 |
| Merck | 2 | $118 |
| Bard Peripheral Vascular, Inc. | 4 | $111 |
| Kerecis Limited | 1 | $101 |
| Johnson & Johnson | 3 | $55 |
| Medtronic | 3 | $53 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $51 |
| Boston Scientific | 2 | $38 |
| Silk Road Medical, Inc. | 2 | $37 |
| Novartis | 2 | $33 |
| Boehringer Ingelheim | 2 | $31 |
| Pacira Pharmaceuticals Incorporated | 1 | $29 |
| Solventum Corporation | 1 | $27 |
| Ambu Inc. | 1 | $24 |
| Convatec Inc. | 1 | $22 |
| Smith+Nephew | 1 | $22 |
| Integra Lifesciences Corporation | 1 | $19 |
| Amgen | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Novo Nordisk | 1 | $14 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,617 in reported general payments places this provider in the 85th percentile of 130 surgical providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 42 | $32,443 |
| ErtapenemErtapenem Sodium | 12 | $5,015 |
| Daptomycin | 12 | $4,774 |
| ClopidogrelClopidogrel Bisulfate | 103 | $702 |
| Cilostazol | 52 | $697 |
| Diclofenac Sodium | 30 | $382 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 16 | $331 |
| Ciprofloxacin Hcl | 29 | $266 |
| Prasugrel Hcl | 12 | $260 |
| Cephalexin | 29 | $219 |
| Gabapentin | 26 | $197 |
| Mupirocin | 26 | $174 |
| Doxycycline Hyclate | 14 | $159 |
| Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide | 14 | $148 |
| Ezetimibe | 16 | $148 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $55 | $32,44342 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 130 surgical providers in Louisiana.
Other surgical in New Orleans
- Richard TubbsNew Orleans$9K
- Keri MorrisNew Orleans$5K
- Bryan SeelyNew Orleans$4K
- Jason CohenNew Orleans$3K
- Ashlyn HarrisNew Orleans$2K
- Jocile HubenthalNew Orleans$2K
- Marie AlexanderNew Orleans$2K
- Jessica NguyenNew Orleans$1K
- Raegen BoudreauxNew Orleans$1K
- Erica Bedu-AnnanNew Orleans$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.